DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference:
- Quentin Blackford, Executive Vice President, Chief Financial Officer; and Matthew Dolan, Vice President Corporate Development will present an update on the company at the BMO Prescriptions for Success Healthcare Conference in New York City, New York on Thursday, December 14, 2017 at 11:00am (EST). The presentation, which will occur live at The Westin Grand Central Hotel, will be concurrently webcast.
The link to the webcasts will be available on the DexCom website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and finally “Events and Webcasts” and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego,
California, is developing and marketing continuous glucose monitoring
systems for ambulatory use by patients and by healthcare providers in
the hospital.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171127005366/en/
Contacts:
Steven R. Pacelli
Executive Vice
President, Strategy and Corporate Development
(858) 200-0200
